AlphaFold predicted structure
USP18 · Q9UMW8

Mean pLDDT
83.4/ 100
Confident
372 residues
Confidence breakdown
- Very high(≥ 90)69%
- Confident(70–90)13%
- Low(50–70)1%
- Very low(< 50)17%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ubiquitin specific peptidase 18
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntracerebral calcification disorders
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalCytopenias and congenital anaemias
BIALLELIC, autosomal or pseudoautosomal+1 more panels — install the extension to see the full list inline on any page.
Congenital intrauterine infection-like syndrome
pseudo-TORCH syndrome
atrial fibrillation
systemic lupus erythematosus
hereditary disease
melanoma
ovarian carcinoma
exocrine pancreatic carcinoma
neoplasm
lung carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Ubl carboxyl-terminal hydrolase 18
Interferon-induced ISG15-specific protease that plays a crucial role for maintaining a proper balance of ISG15-conjugated proteins in cells (PubMed:11788588). Regulates protein ISGylation by efficiently cleaving ISG15 conjugates linked via isopeptide bonds. Regulates T-cell activation and T-helper 17 (Th17) cell differentiation by deubiquitinating TAK1, likely to keep TAK1-TAB complexes in steady conditions (PubMed:23825189). In turn, restricts activation of NF-kappa-B, NFAT, and JNK as well as expression of IL2 in T-cells after TCR activation (PubMed:23825189). Acts as a molecular adapter with USP20 to promote innate antiviral response through deubiquitinating STING1 (PubMed:27801882). Involved also in the negative regulation of the inflammatory response triggered by type I interferon (PubMed:27325888, PubMed:28165510). Upon recruitment by STAT2 to the type I interferon receptor subunit IFNAR2 interferes with the assembly of the ternary interferon-IFNAR1-IFNAR2 complex and acts as a negative regulator of the type I interferon signaling pathway (PubMed:28165510)
USP18 · Q9UMW8

Mean pLDDT
83.4/ 100
Confident
372 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0